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Abstract
Background: b-Amyloid peptide (Ab) is a major protein in the brain associated with Alzheimer’s and Parkinson’s
diseases. The purpose of this study was to investigate the role of macrophage antigen-1 (MAC1) receptor, an
integrin scavenger receptor in microglia, and subsequent signaling events in mediating Ab-induced neurotoxicity.
We have previously reported that NADPH oxidase (PHOX) on microglia and superoxide produced by PHOX are
critical for Ab-induced loss of dopaminergic neurons. However, the upstream signaling pathway of superoxide
production remains unclear.
Methods: For the in vitro study, mesencephalic neuron-glia cultures and microglia-enriched cultures from mice
deficient in the MAC1 receptor (MAC1
-/-) and wild type controls were used to investigate the role of MAC1
receptor in Ab-induced neurotoxicity and the role of phosphoinositide-3 kinase (PI3K) in the signal pathway
between MAC1 receptor and PHOX. For the in vivo study, Ab was injected into the substantia nigra of MAC1
-/-
mice and wild type mice to confirm the role of MAC1 receptor.
Results: W ef o u n dt h a tA b-induced activation of microglia, activation of PHOX, generation of superoxide and other
reactive oxygen species, and loss of dopaminergic neurons were decreased in MAC1
-/- cultures compared to
MAC1
+/+ cultures. In MAC1
-/- mice, dopaminergic neuron loss in response to Ab injection into the substantia nigra was
reduced relative to MAC1
+/+ mice. Thus, MAC1 receptor-mediated PHOX activation and increased superoxide production
are associated with Ab-induced neurotoxicity. PI3K activation was one downstream step in MAC1 signaling to PHOX and
played an important role in Ab-induced neurotoxicity. In microglia-enriched cultures from MAC1
-/- mice, Ab-induced
activation of PI3K (phosphorylation of target proteins and PIP3 production) was reduced relative to MAC1
+/+ cultures.
Conclusions: Taken together, our data demonstrate that Ab activates MAC1 receptor to increase the activity of
PI3K, which in turn phosphorylates p47
phox, triggers the translocation of cytosolic subunits of PHOX to microglia
membrane, increases PHOX activation and the subsequent production of superoxide and causes neurotoxicity.
Background
b-Amyloid peptide (Ab) has been reported to exist
in numerous diseases such as Alzheimer’s disease
(AD), Parkinson’s disease (PD), age-related macular
degeneration and Lewy body disease with dementia
[1-3]. Immunohistochemical analysis reveals that Ab
deposits in the brain are surrounded by and infiltrated
by activated microglia [4,5], suggesting that microglia
are involved in the pathogenesis of amyloid-related
diseases.
The major purpose of this paper was to study the
molecular signaling events mediating the neurotoxicity
of Ab. The essential role of microglia in mediating
Ab-elicited neurotoxicity was extensively compared in
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published paper and the results showed that they were
qualitatively similar [6]. This similarity in Ab-elicited
toxicity in both cortical vs. midbrain cultures was
further demonstrated in the present study. Thus, we
believe that the signaling pathway mediating Ab-elicited
neurotoxicity obtained fromm i d b r a i nc u l t u r e ss h o u l d
be applicable to the cortical cultures. The main reason
for using midbrain dopamine neuron-microglia cultures
for the mechanistic studies in this paper was due to its
unique features: 1) the high density of microglia (about
5 times more than cortical cultures) and 2) higher sensi-
tivity of dopamine neurons to oxidative damage in the
midbrain cultures. For these reasons, midbrain culture
has been widely used for studying the role of microglia
in oxidative insult-related neurotoxicity. For the same
reason, we selected substantia nigra (SN) in the in vivo
study so that we could quantitatively measure specific
damage of dopamine neurons in a much precise and
reproducible manner.
The present study is concerned with how Ab signaling
leads to the activation of NADPH oxidase (PHOX). We
tested the hypothesis that signaling is mediated by
macrophage antigen complex-1 (MAC1) receptor.
MAC1 (integrin CD11b/CD18 receptor) is both an
adhesion molecule and a pattern recognition receptor
that has long been recognized to regulate diverse func-
tions involved in adhesion, migration, phagocytosis and
chemotaxis [7,8]. MAC1 was previously identified as a
TLR4-independent receptor for lipopolysaccharide (LPS)
in phagocytes [9]. MAC1 is elevated in the brains of
post mortem AD patients [10] and in the 1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine (MPTP) animal model
of PD [11], suggesting a role for MAC1 in neurodegen-
eration. MAC1 receptor is essential for phagocytosis of
multiple compounds and the activation of phagocytes in
response to a diverse set of stimuli [12,13]. MAC1 is
also associated with respiratory burst in neutrophils [8],
suggesting that it may be a potential source of micro-
glia-derived oxidative stress. It has also been reported
that MAC1 plays a role in PHOX activation in response
to oxidative insults [8,12,14]. Other evidence suggests
that MAC1 occupancy is capable of triggering the tran-
scription factor nuclear factor-B( N F - B) signaling
pathway and the subsequent production of inflammatory
factors [15,16]. There is increasing evidence that pattern
recognition receptors (i.e. TLR4, scavenger receptors,
and MAC1) associated with phagocytes are critical in
mediating neurotoxic effects. Recently, we reported that
microglial MAC1 receptor plays a critical role in med-
iating neurotoxicity induced by LPS, a-synuclein and
MPTP [17-19].
Here, we implicate the MAC1 receptor in Ab-induced
microglial activation, and Ab-induced neurotoxicity, in
vitro and in vivo. We show that MAC1 signals through
Phosphoinositide-3 kinase (PI3K) to activate PHOX-
mediated superoxide generation and neurotoxicity.
Methods
Reagents
Ab(1-42) was purchased from the American Peptide
Company (Sunnyvale, CA, USA). WST-1 was purchased
from Dojindo Laboratories (Gaithersburg, MD). Cell
culture ingredients were obtained from Invitrogen
(Carlsbad, CA). [
3H] dopamine (30 Ci/mmol) and
[2,3-
3H] g-Aminobutyric acid (GABA) (81 Ci/mmol) was
purchased from Perkin Elmer Life Sciences (Boston,
MA). The polyclonal antibody against tyrosine hydroxy-
lase (TH) was a kind gift from Dr. John Reinhard of
GlaxoSmithKline (Research Triangle Park, NC). Mono-
clonal antibody against the F4/80 was obtained from Ser-
otec (Raleigh, NC). Polyclonal antibody against Iba1 was
obtained from Wako Chemicals USA, Inc. (Richmond,
VA). Vectastain avidin-biotinylated enzyme complex, bio-
tinylated horse anti-mouse and goat anti-rabbit secondary
antibodies were purchased from Vector Laboratories
(Burlingame, CA). Rabbit anti-p47
phox antibody was
obtained from Upstate (Lake Placid, NY). FITC-conjugated
goat anti-rabbit IgG antibody was obtained from Jackson
ImmunoResearch Laboratories (West Grove, PA). Rabbit
anti-GAPDH, rabbit anti-AKT (phosphor S473) antibodies
were obtained from Abcam (Cambridge, MA). Mouse anti-
gp91
phox antibody was purchased from BD Transduction
Laboratories (San Jose, CA). Rabbit anti-PI3K p110 antibody
was purchased from Santa Cruz Biotechnology, Inc. FITC-
conjugated anti phosphoinositide(3,4,5)bisphosphate (PIP3)
antibody was purchased from Echelon Bioscience (Salt Lake
City, UT, USA). All other reagents were purchased from
Sigma-Aldrich (St. Louis, MO).
Animals
Male B6.129S4-Itgam
tm1Myd/J (MAC1
-/-,o naC 5 7 B L / 6 J
background) and C57BL/6J (MAC1
+/+)m i c ew e r ep u r -
chased from Jackson Laboratories (Bar Harbor, Maine).
All the animals were housed in a specific pathogen free
facility, and fed a standard laboratory chow ad libitum.
Housing, breeding and experimental use of the animals
were performed in strict accordance with the National
Institutes of Heath guidelines.
Ab preparation
The peptide (1-42) was reconstituted in PBS, pH 7.4 at a
concentration of 100 μM. Aliquots of stocks were incu-
bated at 37°C for 3 days to form amyloid fibrils.
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Male MAC1
-/- and MAC1
+/+ mice were anesthetized
with sodium pentobarbital (80 mg/kg) and positioned in
a small animal stereotaxic apparatus. Injection of Ab
into SN was made using the flowing stereotaxic coordi-
nates, measured from bregma: 3.0 mm posterior, 1.7
mm lateral, and 4.7 mm ventral. Ab (2 μgi n1μlo fs a l -
ine) was injected into the right side of the SN over a
period of 2 min, and the injection needle was kept in
place for 2 min after the injection. A control injection
of saline alone was made into the left side of SN under
the conditions described above. Ten animals were used
for each strain.
Analysis of neurotoxicity
For the in vivo study, 24 consecutive coronal brain
slices (35-μm thickness), which encompassed the entire
SN, compact part, were collected. A normal distribu-
tion of the number of TH-positive neurons in the SN,
compact part was constructed based on the counts
of 24 slices from MAC1
-/- mice and MAC1
+/+ mice.
The distribution curves from these two noninjected
groups superimpose and show no difference in number
a n ds h a p eo ft h ec u r v e s .E i g h te v e n l ys p a c e db r a i n
slices from saline or Ab-injected animals were immu-
nostained with an antibody against TH and subse-
quently TH-positive neurons were counted. The
distribution of the cell numbers from each animal was
matched with the normal distribution curve to correct
for errors resulting from the cutting of the brain.
Three individuals performed counting in a double-
blind manner. Conclusions were drawn only when the
difference was within 5%.
Primary mesencephalic mixed neuron-glia cultures
Primary mesencephalic mixed neuron-glia cultures were
prepared from the brains of embryonic day 13 ± 0.5
MAC1
+/+ and MAC1
-/- mice as previously described
[20]. Briefly, the ventral midbrain portion of the
embryonic brain was dissected under a microscope and
kept in cold minimum essential medium (MEM).
Mesencephalic tissues were isolated and dissociated with
gentle mechanical trituration. Cells were diluted to 1.5 ×
10
6/ml in maintenance medium (MEM supplemented
with 10% heat-inactivated fetal bovine serum (FBS), 10%
heat-inactivated horse serum, 1 g/L glucose, 2 mM L-
glutamine, 1 mM sodium pyruvate, 100 μMn o n - e s s e n -
tial amino acids, 50 U/ml penicillin, and 50 μg/ml strep-
tomycinand) and seeded in 24-well culture plates
pre-coated with poly-D-lysine (20 μg/ml). Plates were
maintained at 37°C in a humidified atmosphere of 5%
CO2 and 95% air. Seven day-old cultures were used for
treatment. The composition of the cells at the time of
treatment was approximately 48% astrocytes, 11%
microglia, 40% neurons with 1% of which being TH-
positive neurons.
Primary mesencephalic microglia-depleted cultures
Twenty-four hours after seeding the cells, 1 mM L-leucine
methyl ester was added to the culture. Two days later,
cultures were changed back to maintenance medium and
were used for treatment 7 days after initial seeding. The
cultures stained with Iba-1 antibody showed less than
0.1% microglia.
Primary cortical neuron-glia culture
Mouse cortical neuron-glia were prepared from
the brains of embryonic day 16 ± 0.5 MAC1
+/+ and
MAC1
-/- mice. The cortex was dissociated by mild
mechanical trituration in MEM. After pelleting by cen-
trifugation, cells were resuspended and plated (5 × 10
5/
well) in 24-well culture plates precoated with poly d-
lysine. Cultures were maintained in the same medium as
described above for mesencephalic neuron-glia cultures.
Seven-day cultures were used for treatment. The com-
position of cortical neuron-glia cultures was determined
by immunostaining with antibodies against Neu-N and
Iba-1. Cortical neuron-glia cultures contained 60% Neu-
N-IR neurons and 3.1% Iba-1-IR microglia. The remain-
ing cells were presumed to be astroglia.
Primary microglia-enriched cultures
Primary microglia-enriched cultures were prepared from
the whole brains of 1-day-old MAC1
+/+ and MAC1
-/-
pups as described previously [20]. Briefly, brain tissues
were triturated after removing the meninges and blood
vessels. Cells were seeded at 5 × 10
7 in a 150 cm
3 cul-
tures flask with Dulbecco’s modified Eagle’sm e d i u m /
F12 (DMEM/F12) containing 10% heat-inactivated FBS,
2 mM L-glutamine, 1 mM sodium pyruvate, 100 μM
non-essential amino acids, 50 U/ml penicillin and 50
μg/ml streptomycin, pH = 7.2. After a confluent mono-
layer of glia cells had been obtained (12-14 days after
initial seeding), microglia were shaken off, collected and
seeded. The purity of microglia is greater than 98%.
Uptake assays for [
3H]dopamine or [
3H]GABA
Cells were incubated for 15 min at 37°C with 1 μm[
3H]
DA or 5 μm[
3H]GABA in Krebs-Ringer buffer (16 mm
NaH2PO4,1 6m mN a 2HPO4, 119 mm NaCl, 4.7 mm
KCl, 1.2 mm MgSO4, 1.3 mm EDTA, pH 7.4). Non-spe-
cific uptake was blocked by 10 μm mazindol for dopa-
mine uptake, or 10 μm NO-711 and 1 mmb-alanine for
GABA uptake. After washing the cells three times with
ice-cold Krebs-Ringer buffer (1 ml/well) and lysing with
1 N NaOH (0.5 ml/well), the lysate was mixed with 15
mL scintillation fluid and radioactivity was determined
with a liquid scintillation counter. The specific [
3H]
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3H]GABA uptake was calculated by sub-
tracting the amount of radioactivity obtained in the pre-
sence of mazindol or NO-711 and b-alanine from that
obtained in the absence of mazindol or NO-711 and
b-alanine.
Immunostaining
Immunostaining was performed as described previously
[20]. Dopaminergic neurons were stained with the anti-
body against TH (1:5000). Microglia were stained with
the antibody raised against F4/80 (1:20) or Iba-1
(1:1000). In brief, brain sections or 3.7% formaldehyde
fixed cultures were treated with 1% hydrogen peroxide
followed by sequential incubation with blocking solution
(PBS containing 1% BSA, 0.4% Triton-X 100 and 4%
appropriate serum), primary antibody, biotinylated sec-
ondary antibody, and Vectastain ABC reagents. After
washing, the bound complex was visualized by incubat-
ing cells with 3, 3`-diaminobenzidine and urea-hydrogen
peroxide tablets dissolved in water. Color development
was terminated by removal of the reagents and washing
the cultures with PBS. Images of in vitro cultures or
brain staining were recorded with an inverted micro-
scope (Nikon, Tokyo, Japan) or Zeiss microscope (Zeiss,
Germany), respectively, connected to a charge-coupled
device camera (DAGE-MTI, Michigan City, IN, USA)
operated with the MetaMorph software (Universal Ima-
ging Corporation, Downingtown, PA, USA).
Superoxide assay
The extracellular superoxide production was determined
by measuring the superoxide dismutase (SOD)-inhibita-
ble reduction of tetrazolium salt, WST-1 as described
before [20] with modifications. Primary microglial
enriched cultures grown in 96-well plates were treated
with Ab or vehicle in 150 μlo fp h e n o lr e d - f r e et r e a t -
ment medium. At 10 min after treatment, 50 μlo f
WST-1 (1 mM) in phenol red-free treatment medium,
with or without SOD (600 units/ml), was added. The
absorbance at 450 nm was read immediately with a
Spectra Max Plus microtiter plate spectrophotometer
(Molecular Devices, Sunnyvale, CA). For the superoxide
assay using microglia-enriched culture, cells were plated
at 1 × 10
5/well in 96-well plate and incubated at 37°C in
a humidified atmosphere of 5% CO2 and 95% air for 12
hours. The cells were washed twice and left in 100 μl
HBSS. Fifty μlH B S S ,P M Ao rA b were added. Then 50
μl of WST-1 (1 mM) in HBSS, with or without SOD
(600 units/ml), was added. The absorbance at 450 nm
was read immediately.
Confocal microscopy
Enriched microglial cells from mice were seeded in
dishes at 5 × 10
4 cells/well and treated with Ab for 10
min. Cells were fixed with 3.7% paraformaldehyde in
PBS for 10 min. After washing with PBS, cells were
incubated with rabbit polyclonal antibody against PIP3
(0.5 μg/ml). Cells were then washed and incubated with
FITC-conjugated goat anti-rabbit antibody. Focal planes
spaced at 0.4 μm intervals were imaged with a Zeiss 510
laser scanning confocal microscope (63X PlanApo 1.4
numerical aperture objective) equipped with LSM510
digital imaging software. Intracellular reactive oxygen
species (iROS) were assessed as follows. Enriched micro-
glial cells from mice were seeded in dishes at 5 × 10
4
cells/well and were incubated with 1 × HBSS containing
5 μM dichlorodihydrofluorescein diacetate (DCFDA) in
the dark for 1 hour. Then cells were treated with Ab for
10 min. Fluorescent images were captured using Zeiss
510 laser scanning confocal microscope.
Cell extract
Whole cell lysates from neuro n - g l i ac u l t u r e sw e r ep r e -
pared with lysis buffer (Cell Signaling, Danvers, MA).
Subcellular fractionation was performed. For subcellular
fractions, microglia cells were lysed in hypotonic lysis
buffer (1 mM EGTA, 1 mM EDTA, 10 mM b-glycero-
phosphate, 10 mM NaF, 1 mM sodium orthovanadate,
2m MM g C l 2, 10 mM dithiothreitol, 1 mM phenyl-
methylsulfonyl fluoride, and 10 μg/ml each of leupeptin,
aprotinin, and pepstatin A), incubated on ice for 30 min,
and then subjected to Dounce homogenization (20-25
s t o k e s ,t i g h tp e s t l eA ) .T h el y s a t e sw e r el o a d e do n t oa
sucrose gradient in lysis buffer (final 0.5 M) and centri-
fuged at 1,600 × g for 15 min. The supernatant above the
sucrose gradient was used as the cytosolic fraction after
centrifugation at 150,000 × g for 30 min. The pellets
were solubilized in 1% Nonidet P-40 hypotonic lysis buf-
fer and were used as membranous fraction.
Western blot analysis
Equal amounts of protein (40 μg/lane) were separated
by 4-12% Bis-Tris-polyacrylamide electrophoresis gel
and transferred to polyvinylidene difluoride membranes
(Novex, San Diego, CA). Membranes were blocked with
5% nonfat milk and incubated with primary antibody
(rabbit anti-p47
phox antibody (1: 2000), rabbit anti-
GAPDH (1:2000), mouse anti-gp91
phox (1:2000) or rabbit
anti-Iba-1 (1:3000)) overnight at 4°C. Membrane was
then incubated with horseradish peroxidase-linked anti-
rabbit or mouse IgG (1:3000) for 1 h at 25°C. ECL Plus
reagents (GE Healthcare, Little Chalfont, Buckingham-
shire, UK) were used for detection.
Statistical analysis
The data were expressed as mean ± SEM. Statistical
significance between two groups was assessed with an
analysis of variance followed by Student’s t-test or
Zhang et al. Journal of Neuroinflammation 2011, 8:3
http://www.jneuroinflammation.com/content/8/1/3
Page 4 of 14nonparametric statistics. Statistical significance between
multiple groups was performed using a one- or two-way
analysis of variance (ANOVA). When ANOVA showed
a significant difference, an LSD multiple comparisons
post-hoc test was performed. A value of p < 0.05 was
considered statistically significant.
Results
Ab-induced dopaminergic and GABAergic neurotoxicity in
neuron-glia cultures was attenuated with the absence of
MAC1
To investigate the role of MAC1 in Ab-induced neuro-
toxicity, mesencephalic neuron-glia cultures prepared
from MAC1
+/+ and MAC1
-/- mice were treated with
vehicle (controls) or 0.5, 1 or 2 μMA b.D o p a m i n e r g i c
neurotoxicity was assessed by dopamine uptake assay
and cell number count/morphological analysis of immu-
nostained TH-positive neurons. Ab exposure caused
concentration-dependent decreases in [
3H] dopamine
uptake (Figure 1A) and the number of TH-positive neu-
rons (Figure 1B) in cultures from MAC1
+/+ and
MAC1
-/- mice. For both measurements, decreases were
significantly less in the MAC1
-/- cultures. Morphological
analysis showed that TH-positive neurons in the Ab-
treated MAC1
+/+ cultures (Figure 1C) displayed much
shorter and less elaborate neurites compared with those
Figure 1 Absence of MAC1 attenuates Ab-induced dopaminergic and GABAergic neurotoxicity in neuron-glia cultures.M i c e( M A C 1
+/+
and MAC1
-/-) mesencephalic neuron-glia cultures in 24-well plates were treated with vehicle medium (control group) or 0.5 μM, 1.0 μM and 2.0
μMA b for 7 days. (A) Ab-induced dopaminergic neurotoxicity was quantified by [
3H] dopamine uptake assay. (B) Numbers of TH-positive cells
remaining in the neuron-glia cultures after vehicle or Ab treatment. (D) Representative light microscopic images are shown for TH-positive
neurons treated with vehicle or Ab. Scale bar: 100 μm. (C) Mice (MAC1
+/+ and MAC1
-/-) cortical neuron-glia cultures in 24-well plates were
treated with vehicle or 1.0 μM, 2.0 μM and 4.0 μMA b for 7 days. Ab-induced GABAergic neurotoxicity was quantified by [
3H] GABA uptake assay.
(E) Mice (MAC1
+/+ and MAC1
-/-) mesencephalic microglia-depleted cultures in 24-well plates were treated with vehicle medium (control group)
or 1.0 μM, 2.0 μM and 4.0 μMA b for 7 days. Ab-induced dopaminergic neurotoxicity was quantified by [
3H] dopamine uptake assay. Results are
from four independent experiments. #: p < 0.05 compared with corresponding vehicle-treated controls. *: p < 0.05 compared with MAC1
+/+
cultures after same treatments.
Zhang et al. Journal of Neuroinflammation 2011, 8:3
http://www.jneuroinflammation.com/content/8/1/3
Page 5 of 14from MAC1
-/- cultures. We also tested Ab-induced
GABAergic neurotoxicity in cortical neuron-glia cul-
tures. We found that Ab exerted a less potent reduction
in GABA uptake in cortical neuron-glia cultures than
DA uptake in mesencephalic neuron-glia cultures
(Figure 1D). Because there are less microglia presented
in cortical neuron-glia cultures than in mesencephalic
neuron-glia cultures (about 3% to 10%), these results
indicate that the presence of glia might potentiate the
toxic effect of Ab and that is the reason that we used
mesencephalic cultures for the rest of the study. Besides,
we found no difference in Ab-induced neurotoxicity in
microglia-depleted cultures prepared from MAC1
+/+
and MAC1
-/- mice (Figure 1E), confirming the role of
microglial MAC1 in the different dopaminergic neuro-
toxicity of Ab that we observed in neuron-glia cultures.
MAC1 is necessary for Ab-induced microglial activation
After demonstrating the important role of MAC1 in
Ab-induced neurotoxicity, we continued to investigate
whether MAC1 expression affects Ab-induced microglial
activation. The total microglial number in the cultures
from MAC1
+/+ and MAC1
-/- mice are comparable (data
not shown). Activation of microglia was assessed using
F4/80 immunostaining in MAC1
+/+ and MAC1
-/- neu-
ron-glia cultures following exposure to Ab. One day after
treatment with Ab, numerous activated microglia, charac-
terized by intensified F4/80 staining and enlarged cell
size, were distributed throughout the MAC1
+/+ culture
(Figure 2A); MAC1
+/+ cultures contained a mixture of
process-bearing ramified microglia and process-free
amoeboid-like microglia. With 2 μMA b,M A C 1
+/+ cul-
tures exhibited more F4/80-positive cells that appeared to
be fully activated microglia with an amoeboid and con-
densed morphology. In cultures from MAC1
-/- mice, Ab-
induced activation of microglia was noticeably less pro-
nounced (Figure 2A). Western blots using antibody for
I b a - 1 ,aw i d e l yu s e dm a r k e rf or microglial activation,
showed elevated Iba-1 expression in Ab-treated MAC1
+/+
cultures but not in MAC1
-/- cultures (Figure 2B and 2C).
MAC1
-/- mice exhibit reduced Ab-induced nigral dopamine
neurotoxicity and microglial activation in vivo
To determine the role of MAC1 in Ab-induced DA neu-
rotoxicity in vivo, we stereotaxically injected Ab (2 μg
in 1 μl of saline) into the substantia nigra (SN) of MAC1
+/+
Figure 2 MAC1 is necessary for Ab-induced microglial activation. Mesencephalic neuron-glia cultures from MAC1
+/+ and MAC1
-/- mice were
treated with vehicle medium (control group) or Ab for 2 days. (A) Cultures were fixed after treatments. Microglia were visualized by
immunostaining of the F4/80 antigen, a microglial marker. The images presented are representative of three independent experiments. Scale bar:
50 μm. (B) Western blot analysis of microglial activation. Cell lysates of cultures from MAC1
+/+ and MAC1
-/- mice were prepared 2 days after vehicle
or 2.0 μMA b treatment and immunoblot analysis was performed for the measurement of Iba1 antigen. GAPDH was used as loading control. (C)
The ratio of densitometry values of Iba1 and GAPDH was analyzed and normalized to respective control. Results are presented as mean ± SEM for
three independent experiments. #: p < 0.05 compared with corresponding vehicle-treated controls. *: p < 0.05 compared with MAC1
+/+ cultures after
same treatments.
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-/- mice. Seven days later, the brains were
removed, and coronal sections through the nigral com-
plex were immunostained with an antibody against tyro-
sine hydroxylase (TH), a marker for dopaminergic
neurons. Although TH-positive neuron counts were
comparable in the saline-injected sides of MAC1
+/+ mice
and MAC1
-/- mice, Ab injection caused a greater loss of
TH-positive neurons in the SN of MAC1
+/+ mice than in
MAC1
-/- mice (Figure 3A). Cell counts revealed a 27%
loss of DA neurons in MAC1
+/+ controls and 17% loss in
MAC1
-/- mutants (Figure 3C). Thus, deletion of MAC1
protected neurons against microglial activation in vivo.
Microglial morphological changes after Ab injection
were also examined in the SN (Figure 3B). Microglia
were stained with an antibody against Iba1. Resident
microglia in both MAC1
+/+ and MAC1
-/- mice express a
basal level of Iba1, appear small and bear thin processes.
Microglial activation, as demonstrated by a dramatic
increase in Iba1 staining, was highly visible in the SN of
MAC1
+/+ mice post-Ab injection. Numerous microglia
assumed a highly activated amoeboid state with an
enlarged cell body and thicker cellular processes com-
pared with corresponding saline-injected control sides.
Ab-induced activation of microglia was less pronounced
in the SN of MAC1
-/- mice, which exhibited minimal
morphological changes. We also obtained the quantita-
tive changes of Iba-1 in midbrain area by western blot
assay. The results showed elevated Iba-1 expression in
Ab-treated MAC1
+/+ mice but not in MAC1
-/- mice
(Figure 3D and 3E). These in vivo findings confirmed
our in vitro result indicating that MAC1 plays a role in
Ab-induced microglial activation and subsequent loss of
dopaminergic neurons in the SN.
Ab-induced ROS production from microglia is reduced in
MAC1
-/- cultures
We previously showed that microglia enhance Ab-
induced toxicity by producing reactive oxygen species,
especially extracellular superoxide [6]. To determine the
role of MAC1 in Ab-induced superoxide production,
Figure 3 Dopaminergic neurons from MAC1-deficient mice are more resistant to Ab-induced neurotoxicity in vivo.T w oμgo fA b were
injected into the right side of adult MAC1
+/+ and MAC1
-/- mouse SN; vehicle saline alone (control group) was injected into the left side. After 7
days, brains were removed, dopaminergic neurons were stained with an antibody against TH and the microglia were stained with an antibody
against Iba-1. Ten animals were used for each group. Dopaminergic neurons were counted in a double-blind manner by three individuals. (A)
Immunocytochemical analysis of TH-positive neurons. (B) Number of TH-positive neurons. (C) Immunocytochemical analysis of microglia. (D)
Western blot analysis of microglial activation in midbrain area. GAPDH was used as loading control. (E) The ratio of densitometry values of Iba1
and GAPDH was analyzed and normalized to respective control. Results are presented as mean ± SEM. #: p < 0.05 compared with corresponding
saline-treated side. *: p < 0.05 compared with MAC1
+/+ mice after same treatments.
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+/+ and
MAC1
-/- mice were exposed to 0.5, 1 and 2 μMA b and
superoxide production was measured. Figure 4A shows
that Ab increased extracellular superoxide in both cul-
tures. However, the increase was significantly reduced
(P < 0.05) in MAC
-/- cultures, indicating a role for
MAC1 in Ab-induced superoxide production. To ensure
the normal function of PHOX itself in MAC1
-/- mice,
microglia-enriched cultures from MAC1
+/+ and
MAC1
-/- mice were treated with vehicle, PMA, a potent
protein kinase C agonist that can directly induce the
production of superoxide catalyzed by PHOX. Although
Ab induced significantly less production of superoxide
in MAC1
-/- microglia compared with that of MAC1
+/+
microglia, MAC1
+/+ and MAC1
-/- microglia demon-
strated the same capacity to produce superoxide after
PMA, indicating an intact capability for PHOX-mediated
superoxide production in these two genotypes. This sug-
gests that the reduced production of superoxide
observed in MAC1
-/- neuron-glia cultures after Ab
exposure cannot be attributed to the malfunction of
PHOX.
We also measured intracellular ROS production
induced by Ab using DCFDA. Enriched microglial cells
from mice were seeded in dishes at 5 × 10
4 cells/well
and were incubated with 1 × HBSS containing 5 μM
DCFDA in the dark for 1 hour. Then cells were treated
with Ab for 10 min. This non-fluorescent compound is
oxidized by intracellular ROS to 2,7-dichlorodihydro-
fluorescein (DCF), which is fluorescent. DCF fluores-
cence stimulated by Ab was detected using laser
confocal scanning microscopy (Figure 4B). No DCF
fluorescence was detected in control cells from
both MAC1
+/+ and MAC1
-/- cultures (Figure 4B I is
MAC1
+/+ control culture and Figure 4B III is MAC1
-/-
control culture). Ab exposure increased DCF fluores-
cence intensity in both cultures, but the increase in
MAC1
-/- cultures was much lower (Figure 4B II and
Figure 4B IV are MAC1
+/+ culture and MAC1
-/- culture
treated with Ab, respectively.). Thus, MAC1 is closely
Figure 4 MAC1 mediates activation of PHOX and production of superoxide. (A) Microglia-enriched cultures from MAC1
+/+ and MAC1
-/-
mice were treated with vehicle medium (control group), Ab or PMA for 10 min. Extracellular superoxide generation was measured by the SOD-
inhibitable reduction of tetrazolium salt, WST-1. (B) Microglia-enriched cultures from MAC1
+/+ and MAC1
-/- mice were incubated with HBSS
containing 5 μM DCFDA in the dark for 1 hour. Then cells were treated with vehicle medium (control group) or Ab for 10 min. Fluorescent
images were captured using Zeiss 510 laser scanning confocal microscope. Scale bar: 25 μm. (C) Western blot assays for p47
phox levels in
membrane fractions of microglia from MAC1
+/+ and MAC1
-/- mice 10 min after vehicle medium (control group) or Ab treatment. (D)
Densitometry analysis was performed with values of p47
phox normalized to loading control and further normalized to control levels. Data are
presented as mean ± SEM from three independent experiments. #: p < 0.05 relative to corresponding vehicle-treated control cultures. *: p < 0.05
relative to MAC1
+/+ cultures after same treatments.
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ROS production in microglia.
MAC1 is critical for Ab-induced activation of PHOX and
subsequent ROS production after Ab treatment
Since extracellular superoxide is an important factor
mediating MAC1-enhanced Ab neurotoxicity [6] and
since PHOX is the key enzyme in extracellular superox-
ide generation in microglia, we investigated whether
PHOX activation depended upon MAC1 expression.
Activation of PHOX requires the translocation of cyto-
plasmic subunits (p47
phox,p 6 7
phox,p 4 0
phox, and Rac)
and their subsequent interaction with the membrane-
spanning flavocytochrome b558 [21]. To determine
whether MAC1 played a role in PHOX activation, mem-
brane translocation of p47
phox was monitored in micro-
glial cultures by western blot following Ab exposure.
We found significantly increased p47
phox levels in the
membrane fraction of MAC1
+/+ microglia, but not
MAC1
-/- microglia 10 minutes after Ab exposure (Figure
4C&4D). In contrast, after Ab exposure, membrane
content of p47
phox in the MAC1
-/- microglia was sub-
stantially reduced. These results suggest the involvement
of MAC1 in p47
phox membrane translocation and thus
PHOX activation induced by Ab.
Ab activates PHOX via PI3K signaling
A recent study has shown that specific interactions
between phox homology (PX) domains and phosphoino-
sitides play a crucial role in the regulation of PX-
domain-containing proteins, and has identified the PX
domain as a phosphoinositide-binding module involved
in cellular signal transduction [22]. We hypothesized
that PI3K mediates Ab-induced PHOX activation
through the PX domains in two subunits of the NADPH
oxidase, p47
phox and p40
phox [23]. Microglial enriched
cultures from MAC1
+/+ mice were pre-treated with
wortmannin, a potent PI3K inhibitor for 30 min after
which the cultures were challenged with Ab.F i g u r e5 A
shows that wortmannin reduced Ab-induced superoxide
production from MAC1
+/+ microglia in a concentration-
dependent manner; wortmannin alone did not alter
Figure 5 PI3K mediates signaling between MAC1 receptor and PHOX. Microglia-enriched cultures from MAC1
+/+ mice were pretreated with
wortmannin for 30 min and then challenged with Ab for 10 min. (A) Extracellular superoxide generation was measured by the SOD-inhibitable
reduction of tetrazolium salt, WST-1. (B) Western blot assays for p47
phox levels in membrane fractions from microglia. (C) Densitometry analysis
was performed with values of p47
phox normalized to loading control and further normalized to control levels. (D) Microglia-enriched cultures
from MAC1
+/+ mice were treated with vehicle medium (control group) or different concentrations of wortmannin for 12 or 24 hours; cell
viability was measured using MTT assay. Data are presented as mean ± SEM for three independent experiments. #: p < 0.05 relative to vehicle-
treated control cultures. *: p < 0.05 relative to Ab-treated cultures.
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city (Figure 5D). Western blot analysis showed 100 nM
wortmannin significantly inhibited the Ab-induced
increase in p47
phox levels in the membrane fraction of
MAC1
+/+ cultures (Figure 5B, C), indicating suppression
of PHOX activation. These results indicate that PI3K
activation is an upstream signal in Ab-induced PHOX
activation in microglia.
MAC1 is necessary for PI3K activation by Ab
Having demonstrated involvement of PI3K in Ab-induced
activation of PHOX, we examined the role of MAC1 in
Ab-induced PI3K activation. Translocation of p110 cata-
lytic subunit of type I PI3K to the membrane is required
for PI3K activation. Western blots showed that a 10 min
Ab exposure of MAC1
+/+ cultures increased the mem-
brane localization of p110 (Figure 6A). In contrast, Ab-
induced p110 translocation to the membrane was signifi-
cantly suppressed in MAC1
-/- cultures. Figure 6B shows
the confocal microscopy results of PIP3 staining before
and after Ab challenge using a monoclonal antibody spe-
cific for PIP3, which is a product of activated PI3K. In
MAC1
+/+ microglial cultures, Ab increased PIP3 staining
within 15 min and the positive staining was localized
mainly in the cytoplasm and perinuclear, indicating the
activation of PI3K. Similar to the p110 translocation
result, Ab-induced increase in PIP3 staining in MAC1
-/-
microglial cultures was much reduced (Figure 6E).
To confirm a role for MAC1 in Ab-induced PI3K acti-
vation, we measured activation of PDK1 and AKT, two
Figure 6 MAC1 is necessary for PI3K activation elicited by Ab. (A) Western blot assays for p110 and PDK levels in membrane fractions of
microglia from MAC1
+/+ and MAC1
-/- mice 10 min after vehicle medium (control group) or Ab treatment. (B) Enriched microglial cells from
MAC1
+/+ and MAC1
-/- mice were treated with vehicle medium (control group) or Ab for 10 min, fixed and permeabilized. I and II are MAC1
+/+
cultures treated with vehicle or Ab, respectively. III and IV are MAC1
-/- cultures treated with vehicle or Ab, respectively. (C) Western blot assays for
pAKT and AKT levels in microglia from MAC1
+/+ and MAC1
-/- mice 10 min after vehicle medium (control group) or Ab treatment. (D)
Densitometry was performed with values normalized to respectively loading control and further normalized to control levels. Cells were
incubated with a rabbit polyclonal antibody against PIP3 and then with a FITC-conjugated goat anti-rabbit antibody. Shown are representative
confocal images. Scale bar: 25 μm. (E) Quantitative analysis of the figures in 6B. Average cellular fluorescence was quantitated from at least 100
separate cellular measurements obtained from each treatment group. Background fluorescence, determined in the absence of fluorescence
labeled antibody, was minimal in both cell populations (data not shown). Experiments were performed at least three times. #: p < 0.05 relative
to corresponding vehicle-treated control cultures. *: p < 0.05 relative to MAC1
+/+ cultures after same treatments.
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second messenger PIP3, which binds to the pleckstrin
homology domain of PDK1, recruiting it to the plasma
membrane where PDK1 is activated by phosphorylation
of its activation loop residue Ser
241 [22]. Ab exposure of
of MAC1
+/+ microglial cultures induced the phosphory-
lation of the membrane-associated PDK1 and AKT
within 15 min. Significantly less p-PDK and pAKT were
found in MAC1
-/- microglial cultures (Figure 6C and
6D). Taken together, these data indicate that MAC1 is
upstream of PI3K in Ab-induced activation of microglia.
Discussion
We demonstrate here that Ab potently activates micro-
glia in part through the activation of MAC1 receptors,
followed by the production of superoxide free radicals,
and leading to neuronal death. These results not only
confirm our earlier observations that the presence of
microglia potentiated the neurotoxicity of Ab,b u ta l s o
reveal several novel findings that illustrated in Figure 7:
(1) a role for MAC1 receptor in Ab-induced microglial
activation, (2) involvement of MAC1 receptor in PHOX
activation which mediates Ab-induced neurotoxicity and
(3) involvement of PI3K in PHOX activation signals by
MAC1 receptor.
In the mature brain, microglia are readily activated in
response to certain cues such as brain injury or immu-
nological stimuli. Activated microglia serve diverse ben-
eficial functions essential to neuronal survival [24,25].
However, with chronic and over-activation, microglia
themselves can be detrimentally neurotoxic by excessive
production of a large array of cytotoxic factors such as
superoxide [26,27]. The signals responsible for micro-
glial dysregulation are diverse, ranging from exposure to
environmental toxins to neuronal death due to brain
damage or genetic diseases.
There has been considerable interest from several
laboratories in identifying microglial surface receptors
that interact with Ab fibrils. Scavenger receptor class A
(SR-A), scavenger receptor-BI (SR-BI) and CD36 [28-30]
El Khoury et al., 1996 J. El Khoury, S.E. Hickman, C.A.
Thomas, L. Cao, S.C. Silverstein and J.D. Loike, Scaven-
ger receptor-mediated adhesion of microglia to beta-
amyloid fibrils, Nat andand and other receptors such as
macrophage colony-stimulating factor receptor (MCSF)
[31], formyl peptide receptor-1 receptor (FPR-1) [32],
receptor for advanced glycation end products (RAGE)
[33], etc have been reported to be the binding sites for
Ab. A series of papers from Dr. Landreth et al. show that
Ab interacts with a microglial surface receptor complex
composed of B-class scavenger receptor CD36, integrin-
associated protein/CD47, and a6b1-integrin [34-37].
MAC1 is a leukocyte integrin expressed on microglia
and it is a versatile adhesion and recognition receptor.
MAC1 plays a critical role in microglial migration via
pathways that include kinase cascades and cytoskeleton
rearrangements, culminating in activation critical for
antimicrobial leukocyte functions. MAC1 is also reported
to cooperatively activate other key adhesion and defense
receptors [38,39]. In addition to above-mentioned func-
tions, recent work from our laboratory has demonstrated
a critical role of MAC1 in mediating the reactivation of
microglia in response to neuronal damage/death, so-
called reactive microgliosis [17-19]. Our studies suggest
that MAC1 serves as a pattern recognition receptor med-
iating the neurodegeneration produced by toxic sub-
stances released from damaged or dead neurons. Since
Ab is one of the constituents in Lewy body, damaged
dopaminergic neurons may release Ab to the extracellu-
lar space and further activate microglia at least partially
through pattern recognition receptor. Results from this
study lend additional support to this possibility.
In the current study, we revealed that MAC1 defi-
ciency mitigated the loss of dopaminergic neurons and
GABAergic neurons induced by Ab exposure, which
Figure 7 b-amyloid signals through microglial MAC1 receptor
and PI3K to PHOX. Microglia exposed to Ab exhibit a respiratory
burst leading to the release of superoxide anion (O2
-). Release of
superoxide is mediated in part through the Ab cell surface receptor
MAC1. Ab engagement of MAC1 receptor leads to the initiation of
complex signaling events mediated by PI3K activation and PIP3
production, which leads to AKT phosphorylation and activation of
PDK. Activation of these signaling cascades is linked to the
activation of PHOX. PHOX plays an essential role in innate immunity
by catalyzing the formation of superoxide. PHOX consists of two
integral membrane proteins, p22
phox and gp91
phox, which together
form a heterodimeric flavoprotein known as cytochrome b558. In
addition, there are four cytosolic components p47
phox, p67
phox,
p40
phox, and the small G-protein Rac. As an important component
for PHOX activation, the GDP/GTP exchange on Rac-1 is reported to
be a point of possible PI3K intervention. PIP3 is reported to bind to
p47
phox and p40
phox, and mediates their phosphorylation[46]; PI3K
signaling pathway may also sometimes be involved in PKC
activation, thus play an important role in the phosphorylation of
p47
phox. The cytosolic components then translocate to the
membrane where they form a complex with cytochrome b558. The
oxidase complex then initiates electron flow and generation of
superoxide through the NADPH-derived electron reduction by the
flavocytochrome. These findings suggest that MAC1 and PI3K are
involved in upstream signaling cascades responsible for activating
PHOX assembly and microglia in response to Ab.
Zhang et al. Journal of Neuroinflammation 2011, 8:3
http://www.jneuroinflammation.com/content/8/1/3
Page 11 of 14indicates that MAC1 is critical in the Ab-induced neu-
rotoxic process. MAC1 deficiency did not change the
sensitivity of neurons per se because Ab exerted same
degree of toxicity in neuron-enriched cultures from
MAC1
-/- and MAC1
+/+ mice. The presence of microglia
with functional MAC1 expression was essential for the
differential sensitivity to Ab neurotoxicity. This conclu-
sion is further supported by the lack of robust microglia
activation in neuron-glia cultures from MAC1
-/- mice
and the in vivo study using MAC1
-/- mice, as measured
by changes in cell morphology and by the release of
pro-inflammatory factors.
In microglia, activated PHOX is a major source of
ROS. Most PHOX products are released into the extra-
cellular space, and it is believed that extracellular ROS
plays a major role in neurotoxicity associated with
microglial activation [20]. Previous studies in our lab
have shown the involvement of PHOX in microglial
activation and associated neurotoxicity induced by Ab
[6]. The neurotoxicity observed in cultures from wild
type mice that induced by Ab was potently attenuated
in cultures from PHOX
-/- mice. Our previous findings,
together with present results showing that involvement
of MAC1 in Ab-induced neurotoxicity, lend credence to
the conclusion that MAC1 receptors are coupled to
PHOX for enzymatic activation and subsequent produc-
tion of superoxide. These conclusions are further sup-
ported by the fact that Ab-induced translocation of
p47
phox from cytosol to cell membrane is substantially
diminished in MAC1
-/- cultures. This conclusion is con-
sistent with earlier reports of MAC1-mediated PHOX
activation in neutrophils [8] and eosinophils [14].
The next question addressed the signaling pathways
mediating the coupling the activation between MAC1
and PHOX. As illustrated in Figure 7, our studies reveal
that PI3K is a key mediator for MAC1 to signal the acti-
vation of PHOX. PI3K is a class of phosphate kinase
that has been implicated in cell signaling pathways that
affect cellular death and longevity as well as many other
processes that have medically important implications
related to disease states [40-42]. The preferred substrate
of class I PI3K is phosphoinositide(4,5)bisphosphate
(PIP2). Phosphorylation of PIP2 by PI3K generates PIP3,
which is an important second messenger that can pro-
mote cell survival, growth, protein synthesis, mitosis,
and motility [43,44]. Numerous studies showed that
PI3K and PIP3 are involved in the regulation of PHOX.
As an important component for PHOX activation, Rac-1
is reported to be a point of possible PI3K intervention
[45]. PIP3 is believed to bind to p47
phox and P40
phox
[46]. PI3K signaling pathway may also be involved in
PKC activation, thus play an important role in the phos-
phorylation of p47
phox [47,48]. The present results not
only show the involvement of PI3K in Ab-induced
PHOX activation, but also suggest that PI3K lies down-
stream of MAC1 receptor (Figure7).
Although strong evidence from this study illustrates
a critical role for MAC1 receptors in mediating Ab-in-
duced neurotoxicity, the inhibition of both dopaminergic
neuronal loss and production of superoxide in
MAC1-deficient mice or microglia was only partial.
These findings indicate that other mechanisms are also
involved in Ab-induced effects. In fact, reports from Dr.
Landreth’s group recently showed that CD14 and Toll-
like receptors 2 and 4 are required for fibrillar Ab-sti-
mulated microglial activation [49].
MAC1 has been reported to bind several cell surface
and soluble ligands including iC3b, ICAM, fibrinogen,
factor X, filamentous hemagglutinin, lipophosphoglycan,
and LPS [50,51].12. M. Diamond, J. Garcia-Aguilar,
J. Bickford, A. Corbi and T. Springer, The I domain is a
major recognition site on the leukocyte integrin Mac-1
for four distinct adhesion ligands. J. Cell Biol. It has
been demonstrated that MAC1 is colocalized with Ab
plaques in the brain, thus, it is highly likely that Ab acti-
vated microglia partly through the binding to MAC1
receptors [52]. To confirm this hypothesis, our ongoing
project is to determine if there is direct binding of Ab
to MAC1. Preliminary data from binding assays and
immunoprecipitation assays both favor our hypothesis
that Ab does bind to MAC1 receptors.
In conclusion, results from this study indicate that
MAC1 receptor is involved in Ab-induced microglial
activation and subsequent neurotoxicity. The present
f i n d i n g sa r ei m p o r t a n tb e c a u s et h e yi d e n t i f ya ne a r l y ,
possibly initiating, event at the microglial plasma mem-
brane. There are substantial interests in identifying
microglial surface molecules that serve in effect as pat-
tern recognition receptors transducing the neurodegen-
erative effects of substances released from damaged or
dead neurons. Interactions involving these putative
microglial pattern recognition receptors may represent
the initial step in reactive microgliosis, leading to pro-
gressive neuronal death in neurodegenerative diseases.
In this regard, MAC1 may provide a target for therapeu-
tic intervention. Development of specific MAC1 recep-
tor antagonists may reduce the activation of the MAC1-
PHOX complex and the subsequent production of
proinflammatory factors, extending neuronal survival.
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